DUPONT CAPITAL MANAGEMENT CORP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$79,426
-15.2%
2,202
-10.2%
0.00%0.0%
Q1 2023$93,680
-84.5%
2,453
-77.0%
0.00%
-86.2%
Q4 2022$605,644
+49.2%
10,644
+3.7%
0.03%
+20.8%
Q3 2022$406,000
-32.4%
10,262
-24.8%
0.02%
-14.3%
Q2 2022$601,000
+144.3%
13,648
+121.5%
0.03%
+180.0%
Q1 2022$246,000
-50.1%
6,162
-49.7%
0.01%
-44.4%
Q4 2021$493,000
-29.2%
12,259
-28.4%
0.02%
-18.2%
Q3 2021$696,000
-17.7%
17,113
-8.1%
0.02%
+10.0%
Q2 2021$846,000
-48.1%
18,629
-52.3%
0.02%
-48.7%
Q1 2021$1,629,000
+11.0%
39,066
+13.7%
0.04%
+25.8%
Q4 2020$1,468,000
+118.8%
34,364
+34.7%
0.03%
+106.7%
Q3 2020$671,000
-33.4%
25,518
-32.0%
0.02%
-31.8%
Q2 2020$1,007,000
+36.8%
37,551
-8.2%
0.02%
+22.2%
Q1 2020$736,000
+1.5%
40,9040.0%0.02%
+12.5%
Q4 2019$725,000
-25.9%
40,904
-15.3%
0.02%
-27.3%
Q4 2017$978,000
+16.7%
48,2700.0%0.02%
+15.8%
Q3 2017$838,000
+233.9%
48,270
+147.0%
0.02%
+216.7%
Q2 2017$251,000
-0.8%
19,5430.0%0.01%0.0%
Q1 2017$253,000
-43.5%
19,543
-56.9%
0.01%
-40.0%
Q4 2016$448,00045,3310.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders